Where Globe Life Stands With Analysts - Globe Life (NYSE:GL)

In the latest quarter, 7 analysts provided ratings for Globe Life (NYSE:GL), showcasing a mix of bullish and bearish perspectives.

Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.

	Bullish	Somewhat Bullish	Indifferent
Total Ratings	1	3	3
Last 30D	0	1	0
1M Ago	0	0	1
2M Ago	0	0	0
3M Ago	1	2	2

Insights from analysts' 12-month price targets are revealed, presenting an average target of $132.14, a high estimate of $188.00, and a low estimate of $105.00. This current average reflects an increase of 10.51% from the previous average price target of $119.57.

Diving into Analyst Ratings: An In-Depth Exploration

An in-depth analysis of recent analyst actions unveils how financial experts perceive Globe Life. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.

Analyst	Analyst Firm	Action Taken	Rating	Current Price Target	Prior Price Target
Thomas Gallagher	Evercore ISI Group	Raises	Outperform	$143.00	$132.00
Suneet Kamath	Jefferies	Raises	Hold	$114.00	$107.00
Ryan Krueger	Keefe, Bruyette & Woods	Raises	Outperform	$125.00	$120.00
John Barnidge	Piper Sandler	Raises	Overweight	$130.00	$118.00
Mark Hughes	Truist Securities	Raises	Hold	$105.00	$90.00
Nigel Dally	Morgan Stanley	Raises	Equal-Weight	$120.00	$110.00
Wilma Burdis	Raymond James	Raises	Strong Buy	$188.00	$160.00

Key Insights:

Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Globe Life. This information provides a snapshot of how analysts perceive the current state of the company.
Rating: Analysts assign qualitative assessments to stocks, ranging from 'Outperform' to 'Underperform'. These ratings convey the analysts' expectations for the relative performance of Globe Life compared to the broader market.
Price Targets: Understanding forecasts, analysts offer estimates for Globe Life's future value. Examining the current and prior targets provides insight into analysts' changing expectations.

Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of Globe Life's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.

Stay up to date on Globe Life analyst ratings.

Delving into Globe Life's Background

Globe Life Inc is an insurance holding company. It provides a variety of life and supplemental health insurance products and annuities to a broad base of customers. The company's core operations are organized into four reportable segments: life insurance, supplemental health insurance, annuities, and investments. Investment activities, conducted by the investment segment, focus on seeking investments with a yield and term appropriate to support the insurance product obligations. These investments generally consist of fixed maturities and, over the long term, the expected yields are considered when setting insurance premium rates and product profitability expectations.

Unraveling the Financial Story of Globe Life

Market Capitalization Analysis: Falling below industry benchmarks, the company's market capitalization reflects a reduced size compared to peers. This positioning may be influenced by factors such as growth expectations or operational capacity.

Revenue Growth: Globe Life displayed positive results in 3 months. As of 30 September, 2024, the company achieved a solid revenue growth rate of approximately 5.15%. This indicates a notable increase in the company's top-line earnings. When compared to others in the Financials sector, the company faces challenges, achieving a growth rate lower than the average among peers.

Net Margin: Globe Life's net margin excels beyond industry benchmarks, reaching 20.82%. This signifies efficient cost management and strong financial health.

Return on Equity (ROE): The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of 6.14%, the company showcases effective utilization of equity capital.

Return on Assets (ROA): Globe Life's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 1.05% ROA, the company effectively utilizes its assets for optimal returns.

Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 0.6.

The Basics of Analyst Ratings

Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter.

Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.

If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along withanalyst success scores in Benzinga Pro.

Which Stocks Are Analysts Recommending Now?

Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. Click here to stay ahead of the market.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

GLGlobe Life Inc

$181.600.05%

Overview

Market News and Data brought to you by Benzinga APIs

To add Benzinga News as your preferred source on Google, click here.